Chemours expects Q2 adjusted EBITDA of $220M-$250M as it targets net leverage below 3.8x by year-end 2026
The Chemours Company · CHEMICALS & ALLIED PRODUCTS · Now $22.32
+6.7% in 3d after detection
Post-detection moves
1h
—
1d
-5.3%
3d
+6.7%
7d
-2.3%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS